Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
77.98 USD | -3.05% | -1.29% | +36.98% |
May. 31 | Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target | MT |
May. 10 | Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.98% | 1.81B | |
+9.50% | 220B | |
+15.99% | 198B | |
+23.70% | 148B | |
+31.76% | 112B | |
+4.68% | 66.17B | |
+15.33% | 52.47B | |
+4.85% | 50.77B | |
-4.07% | 38.97B | |
-0.40% | 35.13B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating